Acetylsalicylic acid Recruiting Phase 2 Trials for Chronic Myeloid Leukemia, Chronic Phase Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04160546Study to Evaluate the Reinduction and Second Stop of TKI With Ponatinib in CML in Molecular Response (ResToP)